Chapter title |
Normal Cerebrospinal Fluid Pyridoxal 5′-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy
|
---|---|
Chapter number | 413 |
Book title |
JIMD Reports, Volume 22
|
Published in |
JIMD Reports, March 2015
|
DOI | 10.1007/8904_2015_413 |
Pubmed ID | |
Book ISBNs |
978-3-66-247452-5, 978-3-66-247453-2
|
Authors |
Alina Levtova, Stephane Camuzeaux, Anne-Marie Laberge, Pierre Allard, Catherine Brunel-Guitton, Paola Diadori, Elsa Rossignol, Keith Hyland, Peter T Clayton, Philippa B Mills, Grant A Mitchell, Peter T. Clayton, Philippa B. Mills, Grant A. Mitchell, Levtova, Alina, Camuzeaux, Stephane, Laberge, Anne-Marie, Allard, Pierre, Brunel-Guitton, Catherine, Diadori, Paola, Rossignol, Elsa, Hyland, Keith, Clayton, Peter T., Mills, Philippa B., Mitchell, Grant A. |
Abstract |
Deficiency of pyridox(am)ine 5'-phosphate oxidase (PNPO, OMIM 610090) is a treatable autosomal recessive inborn error of metabolism. Neonatal epileptic encephalopathy and a low cerebrospinal fluid (CSF) pyridoxal 5'-phosphate level are the reported hallmarks of PNPO deficiency, but its clinical and biochemical spectra are not fully known. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 24% |
Other | 2 | 12% |
Student > Doctoral Student | 2 | 12% |
Student > Master | 2 | 12% |
Student > Bachelor | 2 | 12% |
Other | 4 | 24% |
Unknown | 1 | 6% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 24% |
Agricultural and Biological Sciences | 4 | 24% |
Medicine and Dentistry | 4 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Psychology | 1 | 6% |
Other | 3 | 18% |